Buy Rimonabant
From News about the best diet drug rimonabant
Buy Rimonabant - Rimonabant (Acomplia) Latest News
|
Rimonabant (Acomplia) , discovered and developed by French pharmaceutical company Sanofi-Synthelabo, is a new drug thas has shown great promise in trials for the treatment of obesity and related metabolic risk factors. Rimonabant is already on the market in Europe, being sold under the trade name Acomplia , and is awaiting approval in the United States. The medication, also known as Acomplia, is still being tested and isn't on the market. Yet reports about the drug's possible benefits which include not only suppressing appetite but also curbing the urge to smoke and improving cholesterol and blood sugar levels -- have many users clamoring for it. "When can I go on this new great drug?" asked one. "I'm overweight and need help fast!". The answer is that the drug's manufacturer, Sanofi-Aventis, plans to apply for FDA approval in 2005. As the first selective CB1 blocker, the effects of rimonabant online on lipid and glucose metabolism, insulin resistance and reduced intra-abdominal adiposity, evidenced by a reduction in waist circumference, have been studied. Abdominal obesity is recognized as a significant risk factor in the development of cardiovascular disease. Buy Rimonabant also because it has been studied by sanofi-aventis as an aid to smoking cessation based on studies for up to one year in over 6,500 smokers motivated to quit smoking. Buy Rimonabant (acomplia), is used in the treatment of obesity and related conditions. CB1 receptor blockade with Acomplia acts to decrease the overactivity of the endocannabinoid system (EC system). The EC system is a recently characterised physiological system that includes receptors such as the CB1 receptor and it has been shown to play an important role in regulating body weight and in controlling energy balance, as well as glucose and lipid (or fat) metabolism. Buy Rimonabant, Acomplia is used complementary to diet and exercise to treat obese or overweight patients who suffer from Type 2 diabetes and abnormal levels of fat in the blood. Sanofi argues that Acomplia can also prevent the risk of cardiovascular disease. Patients with large waist circumference (102 cm in men and 88 cm in women) will mostly benefit from taking the drug. Rimonabant, perhaps in combination with other drugs, may in fact prove to be a useful tool in the fight against obesity and its adverse health effects. But it's not going to be the magic bullet that many users are evidently hoping for. Buy Rimonabant from known companies, even if you buy generic acomplia or brand acomplia, try to find a known company. Buy rimonabant online, an anorectic anti obesity drug. It is a CB1 cannabinoid receptor antagonist. Rimonabant has been found to stop food craving enough to help people lose weight, and could also help curb other unhealthy urges, such as smoking. Rimonabant works by selectively targeting and blocking the CB1 receptors, helping normalize the over-activation of the EC system and making hunger or cigarette pangs more manageable. Much of the excitement about Rimonabant (Acomplia) stems from early results suggesting that the blocking of signals that control cravings not only facilitates weight loss, but that it also improves cardiovascular/ metabolic risk factors in overweight/obese patients.In the RIO-Lipids trial, weight loss was accompanied by a decrease in waist size of 3.4 inches demonstrating a significant reduction in abdominal obesity, an independent marker for heart disease. Dramatic improvements also were reported in lipid profile with a 23% increase in HDL-cholesterol (good cholesterol) and a 15% decrease in triglycerides. Improvements in glucose tolerance and insulin levels were also reported. Approximately half of the patients diagnosed at the start of the study with metabolic syndrome, who received the higher 20 mg daily dose of Acomplia, no longer had this condition at the conclusion of the trial. Buy Acomplia Rimonabant online with us and we assure you of timely delivery of original product. We understand your pain and leave no stone unturned to make your online shopping free from any hassles. Clinical Studies have shown that 33% of people taking Rimonabant lost 10% of body weight and kept their weight down for two years which is extremely newsworthy as no other diet drug has accomplished this for so long a period. It also holds huge potential for the obese individual who also wants to kick the smoking habit apparently also help out in cocaine, marijuana and alcohol additions. Rimonabant may also be found to be effective in assisting some smokers to quit smoking. Sanofi-Aventis is currently conducting studies to determine the possible value of rimonabant in smoking-cessation therapy. The Studies with Rimonabant and Tobacco Use (STRATUS) Program involves more than 6,000 subjects. STRATUS is designed to explore two smoking-related therapies: first, to use rimonabant directly to aid in smoking cessation; second, to help prevent weight gain in former smokers. Initial results apparently suggest that rimonabant is effective for both uses. However, the FDA has explicitly stated to Sanofi-Aventis that without additional studies rimonabant cannot be approved in the United States for smoking cessation therapy. According to Cochrane review in 2007, you may buy rimonabant as Rimonabant "may increase the odds of quitting approximately 1(1/2) fold". Buy Rimonabant because, Rimonabant reduced resumption of cocaine-seeking responses triggered by two of the three most common triggers of relapse in humans, priming and cues. It may also reduce ethanol and opiate seeking behavior.
